View in EDS HTML Full Text PDF Full Text

A 3-Year Multicentric Study on Switching from Ustekinumab to Guselkumab in Partial Responders with Psoriasis—IL PSO (Italian Landscape Psoriasis).

Saved in:
Bibliographic Details
Title: A 3-Year Multicentric Study on Switching from Ustekinumab to Guselkumab in Partial Responders with Psoriasis—IL PSO (Italian Landscape Psoriasis).
Authors: Valenti, Mario1,2 (AUTHOR) mario.valenti@hunimed.eu, Ibba, Luciano1,2 (AUTHOR), Cascio Ingurgio, Ruggero1,2 (AUTHOR), Malagoli, Piergiorgio3 (AUTHOR), Carugno, Andrea4 (AUTHOR), Campoli, Marco4 (AUTHOR), Carrera, Carlo G.5 (AUTHOR), Gaiani, Francesca M.3 (AUTHOR), Strippoli, Davide6 (AUTHOR), Mola, Federica7 (AUTHOR), Marzano, Angelo V.5,8 (AUTHOR), Zerbinati, Nicola4 (AUTHOR), Minuti, Anna4 (AUTHOR), Costanzo, Antonio1,2 (AUTHOR), Narcisi, Alessandra1 (AUTHOR)
Source: Dermatology & Therapy. Nov2024, Vol. 14 Issue 11, p2987-2997. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938210
DOI:10.1007/s13555-024-01270-5